CDMO Services
Cell & Gene Therapy
Partner focused. Patient driven.
Your global provider of tailored CGT solutions.
C3i has built a one-stop shop in the development chain of Cell & Gene Therapy.
We work closely with our clients to manufacture products destined for patients all over the world. C3i prides itself on delivering, on time, quality results on behalf of its clients and for patients, advanced cell and gene products that meet regulatory requirements around the world.
Our Purpose
We work with our clients to ensure we put patients first. We are driven to perform our best knowing that the cells in our hands may be the patient's only chance at survival.
Our People
We are dedicated and highly trained personnel with over 15 years of experience in cell therapy and cGMP manufacturing.
Our Facility
C3i is the only fully validated cGMP center in Canada compliant with FDA, EMA, and Health Canada regulations with commercial capacity.
Fully integrated in-house and on-site services to ensure seamless communication between all parties
We are a CDMO that develops, translates, and manufactures complex cell and gene therapies with a very high success rate. Our strength lies in working with our partners to advance the industry’s ability to bring cell and gene therapy research to market.
We are an extension of your team
C3i works as part of your team proudly blurring the lines between “you“ and “us” to the most desirable “we.” We are the CDMO for cell and gene therapy that fills the gap between your research and innovative patient therapies.
Read the latest news
-
May 11, 2025
C3i at ISCT 2025: An International Showcase for Our CDMO Capabilities
Read MoreA strategic gathering at the crossroads of innovation, regulation, and global partnerships From May 7 to 10, 2025, C3i participated in the International Society for Cell & Gene Therapy (ISCT), a major global conference held this year in New Orleans. Bringing together leading experts and organizations in the field, ISCT serves as a key hub […]
-
May 09, 2025
C3i Wins the 2025 Orchidée Innovation Award at the ESTim Gala
Read MoreA recognition of innovation serving health and the community C3i Center is proud to have received the Prix Orchidée Innovation 2025, presented by the Chambre de commerce de l’Est de Montréal (CCEM) during the ESTim Gala held on May 8. This prestigious award celebrates our ability to turn bold ideas into tangible solutions that advance […]
-
May 01, 2025
C3i at Effervescence Montréal 2025: A Must-Attend Event for Innovative Therapies
Read MoreAn active presence at the heart of discussions on regenerative medicine On April 30, Yvan Côté, President and CEO of C3i, took part in Effervescence Montréal 2025, a key event bringing together key players from research, innovation, and the life sciences industry. Organized by ThéCell – Québec’s Cell, Tissue and Gene Therapy Network, this year’s […]

Make great strides in your career at C3i
C3i offers a wide range of opportunities for you to contribute to our mission of advancing cell and gene therapy.